Gleiss Lutz offers longstanding expertise in statutory health insurance issues and advises on pharmaceutical pricing law matters as well as contractual and data protection issues. The team also regularly leads in court, arbitration and administrative proceedings, most recently in connection with care management, fee regulations and recourse claims by Covid-19 vaccine manufacturers pertaining to exemption agreements. The team is led by Martin Viciano Gofferje, who focuses on transactions and joint ventures, and Reimar Buchner (administrative and medical law). Christine Mattes cover matters at the interface between health and procurement law, where she regularly advises both clients and buyers. Enno Burk was appointed to partner in January 2024 and handles pharmaceutical and medical device law matters with a particular focus on digitisation.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
'We have always received competent support in a timely manner in critical situations. Even when our main contact person was absent, this was ensured by a substitute. All appointments are kept to the utmost precision.'
'Marco König has given us optimal support at all times.'
Key clients
- AOK-Bundesverband
- kubus IT GbR
Work highlights
Advising and representing the Federal Republic of Germany (Federal Ministry of Health/Paul Ehrlich Institute/Federal Institute for Drugs and Medical Devices) in the defense against recourse claims by COVID-19 vaccine manufacturers due to exemption agreements under EU treaties.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Next Generation Partners
Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.
Christine Mattes
Practice head
Reimar Buchner ; Martin Viciano Gofferje
Other key lawyers
Marco König ; Enno Burk; Andreas Neun; Christian Hamann; Christine Mattes